Gene delivery for periodontal tissue engineering: Current knowledge - Future possibilities

Current Gene Therapy

Volumn 9, Issue 4, 2009, Pages 248-266

  Chen, Fa Ming ^a   Ma, Zhi Wei ^a   Wang, Qin Tao ^a   Wu, Zhi Fen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Controlled release; Extracellular matrix; Gene delivery; Gene therapeutics; Growth factors; Periodontal regeneration; Regenerative medicine; Tissue engineering

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; COLLAGEN; DEXTRAN DERIVATIVE; GROWTH FACTOR; LENTIVIRUS VECTOR; MACROGOL; NANOPARTICLE; OSTEOGENIC PROTEIN 1; OSTEOGENIN; PARVOVIRUS VECTOR; PLATELET DERIVED GROWTH FACTOR; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYSACCHARIDE; RETROVIRUS VECTOR; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CELL MIGRATION; CELL PROLIFERATION; CEMENTUM; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE DELIVERY SYSTEM; HUMAN; HYDROGEL; IN VIVO STUDY; NONVIRAL GENE DELIVERY SYSTEM; PERIODONTAL DISEASE; PROTEIN FUNCTION; REVIEW; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE; WOUND HEALING;

EXTRACELLULAR MATRIX; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PERIODONTAL DISEASES; PERIODONTIUM; PLASMIDS; REGENERATION; TISSUE ENGINEERING; WOUND HEALING;

EID: 70349968042     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652309788921071     Document Type: Review

References (162)

1. Zohar R, Tenenbaum HC. How predictable are periodontal regenerative procedures? J Can Dent Assoc 2005; 71: 675-80.
2. Elangovan S, Srinivasan S, Ayilavarapu S. Novel regenerative strategies to enhance periodontal therapy outcome. Expert Opin Biol Ther 2009; 9: 399-410.
3. Trombelli L. Which reconstructive procedures are effective for treating the periodontal intraosseous defect? Periodontol 2000 2005; 37: 88-105.
4. Aichelmann-Reidy ME, Reynolds MA. Predictability of clinical outcomes following regenerative therapy in intrabony defects. J Periodontol 2008; 79: 387-93.
5. Nanci A, Bosshardt DD. Structure of periodontal tissues in health and disease. Periodontol 2000 2006; 40: 11-28.
6. Bartold PM, Narayanan AS. Molecular and cell biology of healthy and diseased periodontal tissues. Periodontol 2000 2006; 40: 29-49.
7. Polimeni G, Xiropaidis AV, Wikesjö UM. Biology and principles of periodontal wound healing/regeneration. Periodontol 2000 2006; 41: 30-47.
8. Kaigler D, Cirelli JA, Giannobile WV. Growth factor delivery for oral and periodontal tissue engineering. Expert Opin Drug Deliv 2006; 3: 647-62.
9. Chen FM, Shelton RM, Jin Y, Chapple IL. Localized delivery of growth factors for periodontal tissue regeneration: role, strategies, and perspectives. Med Res Rev 2009; 29: 472-513.
10. Luginbuehl V, Meinel L, Merkle HP, Gander B. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004; 58: 197-208.
11. Vasita R, Katti DS. Growth factor-delivery systems for tissue engineering: a materials perspective. Expert Rev Med Devices 2006; 3: 29-47.
12. Giannobile WV, Somerman MJ. Growth and amelogenin-like factors in periodontal wound healing. A systematic review. Ann Periodontol 2003; 8: 193-204.
13. Hughes FJ, Turner W, Belibasakis G, Martuscelli G. Effects of growth factors and cytokines on osteoblast differentiation. Periodontol 2000 2006; 41: 48-72.
14. Dereka XE, Markopoulou CE, Vrotsos IA. Role of growth factors on periodontal repair. Growth Factors 2006; 24: 260-67.
15. Hallman M, Thor A. Bone substitutes and growth factors as an alternative/ complement to autogenous bone for grafting in implant dentistry. Periodontol 2000 2008; 47: 172-92.
16. Ramseier CA, Abramson ZR, Jin Q, Giannobile WV. Gene therapeutics for periodontal regenerative medicine. Dent Clin North Am 2006; 50: 245-63.
17. Kofron MD, Laurencin CT. Bone tissue engineering by gene delivery. Adv Drug Deliv Rev 2006; 58: 555-76.
18. Phillips JE, Gersbach CA, García AJ. Virus-based gene therapy strategies for bone regeneration. Biomaterials 2007; 28: 211-29.
19. Betz VM, Betz OB, Harris MB, Vrahas MS, Evans CH. Bone tissue engineering and repair by gene therapy. Front Biosci 2008; 13: 833-41.
20. Taba M Jr, Jin Q, Sugai JV, Giannobile WV. Current concepts in periodontal bioengineering. Orthod Craniofac Res 2005; 8: 292-302.
21. Karthikeyan BV, Pradeep AR. Gene therapy in periodontics: a review and future implications. J Contemp Dent Pract 2006; 7: 83-91.
22. Nakahara T. A review of new developments in tissue engineering therapy for periodontitis. Dent Clin North Am 2006; 50: 265-76.
23. Atala A. Recent developments in tissue engineering and regenerative medicine. Curr Opin Pediatr 2006; 18: 167-71.
24. Nussenbaum B, Krebsbach PH. The role of gene therapy for craniofacial and dental tissue engineering. Adv Drug Deliv Rev 2006; 58: 577-91.
25. Cortellini P, Labriola A, Tonetti MS. Regenerative periodontal therapy in intrabony defects: state of the art. Minerva Stomatol 2007; 56: 519-39.
26. Grzesik WJ, Narayanan AS. Cementum and periodontal wound healing and regeneration. Crit Rev Oral Biol Med 2002; 13: 474-84.
27. Zeichner-David M. Regeneration of periodontal tissues: cemento-genesis revisited. Periodontol 2000 2006; 41: 196-217.
28. Gonçalves PF, Lima LL, Sallum EA, Casati MZ, Nociti FH Jr. Root cementum may modulate gene expression during periodontal regeneration: a preliminary study in humans. J Periodontol 2008; 79: 323-31.
29. Moioli EK, Clark PA, Xin X, Lal S, Mao JJ. Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev 2007; 59: 308-24.
30. Lynch SE, de Castilla GR, Williams RC, et al. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 1991; 62: 458-67.
31. Lynch SE, Buser D, Hernandez RA, et al. Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. J Periodontol 1991; 62: 710-6.
32. Shih SD, Rees TD, Miller EG, Wright JM, Iacopino AM. The effects of platelet-derived growth factor-BB and insulin-like growth factor-1 on epithelial dysplasia. J Periodontol 1996; 67: 1224-32.
33. Sant'Ana AC, Marques MM, Barroso TE, Passanezi E, de Rezende ML. Effects of TGF-beta1, PDGF-BB, and IGF-1 on the rate of proliferation and adhesion of a periodontal ligament cell lineage in vitro. J Periodontol 2007; 78: 2007-17.
34. Zaman KU, Sugaya T, Kato H. Effect of recombinant human platelet-derived growth factor-BB and bone morphogenetic protein-2 application to demineralized dentin on early periodontal ligament cell response. J Periodontal Res 1999; 34: 244-50.
35. Ripamonti U, Crooks J, Petit JC, Rueger DC. Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein-1 and bone morphogenetic protein-2. A pilot study in Chacma baboons (Papio ursinus). Eur J Oral Sci 2001; 109: 241-8.
36. Raiche AT, Puleo DA. Cell responses to BMP-2 and IGF-I released with different time-dependent profiles. J Biomed Mater Res A 2004; 69: 342-50.
37. Raiche AT, Puleo DA. In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials 2004; 25: 677-85.
38. Holland TA, Tabata Y, Mikos AG. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 2005; 101: 111-25.
39. Quaglia F. Bioinspired tissue engineering: the great promise of protein delivery technologies. Int J Pharm 2008; 364: 281-97.
40. Kao RT, Conte G, Nishimine D, Dault S. Tissue engineering for periodontal regeneration. J Calif Dent Assoc 2005; 33: 205-15.
41. Ripamonti U, Herbst NN, Ramoshebi LN. Bone morphogenetic proteins in craniofacial and periodontal tissue engineering: experimental studies in the non-human primate Papio ursinus. Cytokine Growth Factor Rev 2005; 16: 357-68.
42. Ripamonti U. Recapitulating development: a template for periodontal tissue engineering. Tissue Eng 2007; 13: 51-71.
43. Ikada Y. Challenges in tissue engineering. J R Soc Interface 2006; 3: 589-601.
44. Ripamonti U, Renton L. Bone morphogenetic proteins and the induction of periodontal tissue regeneration. Periodontol 2000 2006; 41: 73-87.
45. Bashutski JD, Wang HL. Role of platelet-rich plasma in soft tissue root-coverage procedures: a review. Quintessence Int 2008; 39: 473-83.
46. Bosshardt DD. Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels. J Clin Periodontol 2008; 35: S87-105.
47. Liu Y, Zheng Y, Ding G, et al. Periodontal ligament stem cell-mediated treatment for periodontitis in miniature swine. Stem Cells 2008; 26: 1065-73.
48. Bleiziffer O, Eriksson E, Yao F, Horch RE, Kneser U. Gene transfer strategies in tissue engineering. J Cell Mol Med 2007; 11: 206-23.
49. Baum BJ, Kok M, Tran SD, Yamano S. The impact of gene therapy on dentistry: a revisiting after six years. J Am Dent Assoc 2002; 133: 35-44.
50. Hu YC. Baculoviral vectors for gene delivery: a review. Curr Gene Ther 2008; 8: 54-65.
51. Ulrich-Vinther M. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Acta Orthop 2007; 78: S1-64.
52. Stiehler M, Duch M, Mygind T, et al. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells. Adv Exp Med Biol 2006; 585: 31-48.
53. Jager L, Ehrhardt A. Emerging adenoviral vectors for stable correction of genetic disorders. Curr Gene Ther 2007; 7: 272-83.
54. Campos SK, Barry MA. Current advances and future challenges in Adenoviral vector biology and targeting. Curr Gene Ther 2007; 7: 189-204.
55. Parker DG, Brereton HM, Coster DJ, Williams KA. The potential of viral vector-mediated gene transfer to prolong corneal allograft survival. Curr Gene Ther 2009; 9: 33-44.
56. Brock P, Sparmann G, Ritter T, Jaster R, Liebe S, Emmrich J. Adenovirus-mediated gene transfer of interleukin-4 into pancreatic stellate cells promotes interleukin-10 expression. J Cell Mol Med 2006; 10: 884-95.
57. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244-5.
58. Franceschi RT. Biological approaches to bone regeneration by gene therapy. J Dent Res 2005; 84: 1093-103.
59. Hawley RG. Progress toward vector design for hematopoietic stem cell gene therapy. Curr Gene Ther 2001; 1: 1-17.
60. Tai CK, Kasahara N. Replication-competent retrovirus vectors for cancer gene therapy. Front Biosci 2008; 13: 3083-95.
61. Schambach A, Baum C. Clinical application of lentiviral vectors - concepts and practice. Curr Gene Ther 2008; 8: 474-82.
62. Wu X, Wakefield JK, Liu H, Kappes JC. Analysis of lenti- and trans-lentiviral vector genetic recombination. Dev Biol (Basel) 2001; 106: 237-48.
63. Snyder RO, Francis J. Adeno-associated viral vectors for clinical gene transfer studies. Curr Gene Ther 2005; 5: 311-21.
64. Ulrich-Vinther M, Stengaard C, Schwarz EM, Goldring MB, Soballe K. Adeno-associated vector mediated gene transfer of transforming growth factor-beta1 to normal and osteoarthritic human chondrocytes stimulates cartilage anabolism. Eur Cell Mater 2005; 10: 40-50.
65. Ulrich-Vinther M, Schwarz EM, Pedersen FS, Soballe K, Andreassen TT. Gene therapy with human osteoprotegerin decreases callus remodeling with limited effects on biomechanical properties. Bone 2005; 37: 751-8.
66. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346-58.
67. Heyde M, Partridge KA, Oreffo RO, Howdle SM, Shakesheff KM, Garnett MC. Gene therapy used for tissue engineering applications. J Pharm Pharmacol 2007; 59: 329-50.
68. Barteau B, Chèvre R, Letrou-Bonneval E, Labas R, Lambert O, Pitard B. Physicochemical parameters of non-viral vectors that govern transfection efficiency. Curr Gene Ther 2008; 8: 313-23.
69. Fischer PM. Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001-2006. Med Res Rev 2007; 27: 755-95.
70. Karmali PP, Chaudhuri A. Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises. Med Res Rev 2007; 27: 696-722.
71. Juillerat-Jeanneret L, Schmitt F. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail. Med Res Rev 2007; 27: 574-90.
72. Li Z, Huang L. Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly(D,L-lactide-co-4-hydroxy-L-proline). J Control Release 2004; 98: 437-46.
73. Arote R, Kim TH, Kim YK, et al. A biodegradable poly(ester amine) based on polycaprolactone and polyethylenimine as a gene carrier. Biomaterials 2007; 28: 735-44.
74. Luten J, van Nostrum CF, De Smedt SC, Hennink WE. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J Control Release 2008; 126: 97-110.
75. Zhang Y, Cheng X, Wang J, et al. Novel chitosan/collagen scaffold containing transforming growth factor-beta1 DNA for periodontal tissue engineering. Biochem Biophys Res Commun 2006; 344: 362-9.
76. Zhang Y, Song J, Shi B, et al. Combination of scaffold and adenovirus vectors expressing bone morphogenetic protein-7 for alveolar bone regeneration at dental implant defects. Biomaterials 2007; 28: 4635-42.
77. Zhang Y, Wang Y, Shi B, Cheng X. A platelet-derived growth factor releasing chitosan/coral composite scaffold for periodontal tissue engineering. Biomaterials 2007; 28: 1515-22.
78. Park TG, Jeong JH, Kim SW. Current status of polymeric gene delivery systems. Adv Drug Deliv Rev 2006; 58: 467-86.
79. Murasawa S, Asahara T. Gene modified cell transplantation for vascular regeneration. Curr Gene Ther 2007; 7: 1-6.
80. Haastert K, Grothe C. Gene therapy in peripheral nerve reconstruction approaches. Curr Gene Ther 2007; 7: 221-8.
81. Gersbach CA, Phillips JE, García AJ. Genetic engineering for skeletal regenerative medicine. Annu Rev Biomed Eng 2007; 9: 87-119.
82. Murray PE, Garcia-Godoy F, Hargreaves KM. Regenerative endodontics: a review of current status and a call for action. J Endod 2007; 33: 377-90.
83. Conrad C, Gupta R, Mohan H, et al. Genetically engineered stem cells for therapeutic gene delivery. Curr Gene Ther 2007; 7: 249-60.
84. Kimelman N, Pelled G, Helm GA, Huard J, Schwarz EM, Gazit D. Review: gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng 2007; 13: 1135-50.
85. Staudacher DL, Flugelman MY. Cell and gene therapies in cardiovascular disease with special focus on the no option patient. Curr Gene Ther 2006; 6: 609-23.
86. Tözüm TF, Demiralp B. Platelet-rich plasma: a promising innovation in dentistry. J Can Dent Assoc 2003; 69: 664.
87. Matsuda N, Lin WL, Kumar NM, Cho MI, Genco RJ. Mitogenic, chemotactic, and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. J Periodontol 1992; 63: 515-25.
88. Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 2000; 96: 2022-36.
89. Gao J, Symons AL, Bartold PM. Expression of transforming growth factor-beta 1 (TGF-beta1) in the developing periodontium of rats. J Dent Res 1998; 77: 1708-16.
90. Saygin NE, Tokiyasu Y, Giannobile WV, Somerman MJ. Growth factors regulate expression of mineral associated genes in cementoblasts. J Periodontol 2000; 71: 1591-600.
91. Nakashima M, Iohara K, Zheng L. Gene therapy for dentin regeneration with bone morphogenetic proteins. Curr Gene Ther 2006; 6: 551-60.
92. Anusaksathien O, Giannobile WV. Growth factor delivery to re-engineer periodontal tissues. Curr Pharm Biotechnol 2002; 3: 129-39.
93. Thomadakis G, Ramoshebi LN, Crooks J, Rueger DC, Ripamonti U. Immunolocalization of bone morphogenetic protein-2 and -3 and osteogenic protein-1 during murine tooth root morphogenesis and in other craniofacial structures. Eur J Oral Sci 1999; 107: 368-77.
94. Zaman KU, Sugaya T, Kato H. Effect of recombinant human platelet-derived growth factor-BB and bone morphogenetic protein-2 application to demineralized dentin on early periodontal ligament cell response. J Periodontal Res 1999; 34: 244-50.
95. Chen F, Wu Z, Wang Q, et al. Preparation and biological characteristics of recombinant human bone morphogenetic protein-2-loaded dextran-co-gelatin hydrogel microspheres, in vitro and in vivo studies. Pharmacology 2005; 75: 133-44.
96. Chen FM, Wu ZF, Wang QT, et al. Preparation of recombinant human bone morphogenetic protein-2 loaded dextran-based microspheres and their characteristics. Acta Pharm Sin 2005; 26: 1093-103.
97. Giannobile WV, Ryan S, Shih MS, Su DL, Kaplan PL, Chan TC. Recombinant human osteogenic protein-1 (OP-1) stimulates periodontal wound healing in class III furcation defects. J Periodontol 1998; 69: 129-37.
98. Jones AA, Buser D, Schenk R, Wozney J, Cochran DL. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model. J Periodontol 2006; 77: 1184-93.
99. Jung RE, Glauser R, Schärer P, Hämmerle CH, Sailer HF, Weber FE. Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 2003; 14: 556-68.
100. Li JZ, Li H, Dunford B, et al. Rat strain differences in the ectopic osteogenic potential of recombinant human BMP adenoviruses. Mol Ther 2003; 8: 822-9.
101. Cheng H, Jiang W, Phillips FM, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003; 85-A: 1544-52.
102. Jin QM, Anusaksathien O, Webb SA, Rutherford RB, Giannobile WV. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol 2003; 74: 202-13.
103. Chen YL, Chen PK, Jeng LB, et al. Periodontal regeneration using ex vivo autologous stem cells engineered to express the BMP-2 gene: an alternative to alveolaplasty. Gene Ther 2008; 15: 1469-77.
104. Dunn CA, Jin Q, Taba M Jr, Franceschi RT, Bruce RR, Giannobile WV. BMP gene delivery for alveolar bone engineering at dental implant defects. Mol Ther 2005; 11: 294-9.
105. Giannobile WV, Hernandez RA, Finkelman RD, et al. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodontal Res 1996; 31: 301-12.
106. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997; 68: 1186-93.
107. Huang Z, Nelson ER, Smith RL, Goodman SB. The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro. Tissue Eng 2007; 13: 2311-20.
108. Zhang Y, Shi B, Li C, et al. The synergetic bone-forming effects of combinations of growth factors expressed by adenovirus vectors on chitosan/collagen scaffolds. J Control Release 2009; 136: 172-8.
109. Giannobile WV, Lee CS, Tomala MP, Tejeda KM, Zhu Z. Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering. J Periodontol 2001; 72: 815-23.
110. Zhu Z, Lee CS, Tejeda KM, Giannobile WV. Gene transfer and expression of platelet-derived growth factors modulate periodontal cellular activity. J Dent Res 2001; 80: 892-7.
111. Jin Q, Anusaksathien O, Webb SA, Printz MA, Giannobile WV. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 2004; 9: 519-26.
112. Anusaksathien O, Webb SA, Jin QM, Giannobile WV. Platelet-derived growth factor gene delivery stimulates ex vivo gingival repair. Tissue Eng 2003; 9: 745-56.
113. Anusaksathien O, Jin Q, Zhao M, Somerman MJ, Giannobile WV. Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum. J Periodontol 2004; 75: 429-40.
114. Lin Z, Sugai JV, Jin Q, Chandler LA, Giannobile WV. Platelet-derived growth factor-B gene delivery sustains gingival fibroblast signal transduction. J Periodontal Res 2008; 43: 440-9.
115. El-Ayoubi R, Eliopoulos N, Diraddo R, Galipeau J, Yousefi AM. Design and fabrication of 3D porous scaffolds to facilitate cell-based gene therapy. Tissue Eng Part A 2008; 14:1037-48.
116. Han X, Amar S. IGF-1 signaling enhances cell survival in periodontal ligament fibroblasts vs. gingival fibroblasts. J Dent Res 2003; 82: 454-9.
117. McCarthy TL, Centrella M, Canalis E. Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J Bone Miner Res 1988; 3: 401-8.
118. Palioto DB, Coletta RD, Graner E, Joly JC, de Lima AF. The influence of enamel matrix derivative associated with insulin-like growth factor-I on periodontal ligament fibroblasts. J Periodontol 2004; 75: 498-504.
119. Ogino Y, Ayukawa Y, Kukita T, Koyano K. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 724-9.
120. Saraf A, Mikos AG. Gene delivery strategies for cartilage tissue engineering. Adv Drug Deliv Rev 2006; 58: 592-603.
121. Miyaji T, Nakase T, Iwasaki M, et al. Expression and distribution of transcripts for sonic hedgehog in the early phase of fracture repair. Histochem Cell Biol 2003; 119: 233-7.
122. Edwards PC, Ruggiero S, Fantasia J, et al. Sonic hedgehog gene-enhanced tissue engineering for bone regeneration. Gene Ther 2005; 12: 75-86.
123. Edwards PC, Mason JM. Gene-enhanced tissue engineering for dental hard tissue regeneration: (1) overview and practical considerations. Head Face Med 2006; 2: 12.
124. Edwards PC, Mason JM. Gene-enhanced tissue engineering for dental hard tissue regeneration: (2) dentin-pulp and periodontal regeneration. Head Face Med 2006; 2: 16.
125. Ghali S, Dempsey MP, Jones DM, Grogan RH, Butler PE, Gurtner GC. Plastic surgical delivery systems for targeted gene therapy. Ann Plast Surg 2008; 60: 323-32.
126. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release 2008; 125: 193-209.
127. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55: 329-47.
128. Díez S, Tros de Ilarduya C. Versatility of biodegradable poly(D,Llactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur J Pharm Biopharm 2006; 63: 188-97.
129. Dass CR, Contreras KG, Dunstan DE, Choong PF. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. Biomaterials 2007; 28: 3026-33.
130. Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005; 109: 256-74.
131. Chen FM, Wu ZF, Sun HH, et al. Release of bioactive BMP from dextran-derived microspheres: a novel delivery concept. Int J Pharm 2006; 307: 23-32.
132. Chen FM, Zhao YM, Wu H, et al. Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres. J Control Release 2006; 114: 209-22.
133. Chen FM, Ma ZW, Dong GY, Wu ZF. Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery. Acta Pharm Sin 2009; 30: 485-93.
134. Agarwal A, Mallapragada SK. Synthetic sustained gene delivery systems. Curr Top Med Chem 2008; 8: 311-30.
135. Yih TC, Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J Cell Biochem 2006; 97: 1184-90.
136. Slowing II, Vivero-Escoto JL, Wu CW, Lin VS. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008; 60: 1278-88.
137. Sanvicens N, Marco MP. Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnol 2008; 26: 425-33.
138. Yang Y, Xu Z, Jiang J, et al. Poly(imidazole/DMAEA) phosphazene/ DNA self-assembled nanoparticles for gene delivery: synthesis and in vitro transfection. J Control Release 2008; 127: 273-9.
139. Xu FJ, Li H, Li J, Zhang Z, Kang ET, Neoh KG. Pentablock copolymers of poly(ethylene glycol), poly((2-dimethyl amino)ethyl methacrylate) and poly(2-hydroxyethyl methacrylate) from consecutive atom transfer radical polymerizations for non-viral gene delivery. Biomaterials 2008; 29: 3023-33.
140. Gao Y, Xu Z, Chen S, Gu W, Chen L, Li Y. Argininechitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency. Int J Pharm 2008; 359: 241-6.
141. Cohen H, Levy RJ, Gao J, et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther 2000; 7: 1896-905.
142. Kang SW, Lim HW, Seo SW, Jeon O, Lee M, Kim BS. Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs. Biomaterials 2008; 29: 1109-17.
143. De Laporte L, Shea LD. Matrices and scaffolds for DNA delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59: 292-307.
144. Kushibiki T, Tabata Y. A new gene delivery system based on controlled release technology. Curr Drug Deliv 2004; 1: 153-63.
145. Nie H, Wang CH. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. J Control Release 2007; 120: 111-21.
146. Fernández-Carballido A, Pastoriza P, Barcia E, Montejo C, Negro S. PLGA/PEG-derivative polymeric matrix for drug delivery system applications: characterization and cell viability studies. Int J Pharm 2008; 352: 50-7.
147. Tabata Y. Current status of regenerative medical therapy based on drug delivery technology. Reprod Biomed Online 2008; 16: 70-80.
148. Saltzman WM, Olbricht WL. Building drug delivery into tissue engineering. Nat Rev Drug Discov 2002; 1: 177-86.
149. Takahashi D, Odajima T, Morita M, Kawanami M, Kato H. Formation and resolution of ankylosis under application of recombinant human bone morphogenetic protein-2 (rhBMP-2) to class III furcation defects in cats. J Periodontal Res 2005; 40: 299-305.
150. Tatakis DN, Wikesjö UM, Razi SS, et al. Periodontal repair in dogs: effect of transforming growth factor-beta 1 on alveolar bone and cementum regeneration. J Clin Periodontol 2000; 27: 698-704.
151. Wikesjö UM, Qahash M, Thomson RC, et al. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier. Clin Implant Dent Relat Res 2003; 5: 112-23.
152. Wikesjö UM, Sorensen RG, Kinoshita A, Jian Li X, Wozney JM. Periodontal repair in dogs: effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 2004; 31: 662-70.
153. Nygaard-Østby P, Bakke V, Nesdal O, Nilssen HK, Susin C, Wikesjö UM. Periodontal healing following reconstructive surgery: effect of guided tissue regeneration using a bioresorbable barrier device when combined with autogenous bone grafting. A randomized controlled clinical trial. J Clin Periodontol 2008; 35: 37-43.
154. Ripamonti U, Richter PW, Nilen RW, Renton L. The induction of bone formation by smart biphasic hydroxyapatite tricalcium phosphate biomimetic matrices in the non-human primate Papio ursinus. J Cell Mol Med 2008; 12: 2609-21.
155. Ripamonti U, Richter PW, Thomas ME. Self-inducing shape memory geometric cues embedded within smart hydroxyapatite-based biomimetic matrices. Plast Reconstr Surg 2007; 120: 1796-807.
156. Chen FM, Zhao YM, Sun HH, et al. Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: Formulation and characteristics. J Control Release 2007; 118: 65-77.
157. Chen FM, Zhao YM, Zhang R, et al. Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins. J Control Release 2007; 121: 81-90.
158. Chen FM, Chen R, Wang XJ, Sun HH, Wu ZF. In vitro cellular responses to scaffolds containing two microencapulated growth factors. Biomaterials 2009; 30: 5215-24.
159. Jang JH, Houchin TL, Shea LD. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices 2004; 1: 127-38.
160. Storrie H, Mooney DJ. Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv Drug Deliv Rev 2006; 58: 500-14.
161. Quaglia F. Bioinspired tissue engineering: the great promise of protein delivery technologies. Int J Pharm 2008; 364: 281-97.
162. Bartold PM, Xiao Y, Lyngstaadas SP, Paine ML, Snead ML. Principles and applications of cell delivery systems for periodontal regeneration. Periodontol 2000 2006; 41: 123-35.